Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jammbe Z Musoro

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
European Journal of Cancer (Oxford, England : 1990)|October 26, 2018
Interpreting European Organisation for Research and Treatment for Cancer Quality of life Questionnaire core 30 scores as minimally importantly different for patients with malignant melanomaJammbe Z Musoro, Andrew Bottomley, Corneel Coens, et al.
Lung Cancer (Amsterdam, Netherlands)|April 12, 2022
Minimally important differences of EORTC QLQ-C30 scales in patients with lung cancer or malignant pleural mesothelioma - Interpretation guidance derived from two randomized EORTC trialsMichael Koller, Jammbe Z Musoro, Krzysztof Tomaszewski, et al.
JNCI Cancer Spectrum|April 25, 2020
Minimally Important Differences for Interpreting EORTC QLQ-C30 Scores in Patients With Advanced Breast CancerJammbe Z Musoro, Corneel Coens, Frederic Fiteni, et al.
Gynecologic Oncology|September 25, 2020
Minimally important differences for interpreting European Organisation for Research and Treatment of Cancer (EORTC) Quality of life Questionnaire core 30 scores in patients with ovarian cancerJammbe Z Musoro, Corneel Coens, Elfriede Greimel, et al.
Head & Neck|July 7, 2020
Minimally important differences for interpreting European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 scores in patients with head and neck cancerJammbe Z Musoro, Corneel Coens, Susanne Singer, et al.
The Lancet. Oncology|May 4, 2023
Single-arm studies involving patient-reported outcome data in oncology: a literature review on current practiceLimin Liu, Jungyeon Choi, Jammbe Z Musoro, et al.
Neuro-Oncology|February 18, 2021
Establishing anchor-based minimally important differences for the EORTC QLQ-C30 in glioma patientsLinda Dirven, Jammbe Z Musoro, Corneel Coens, et al.
European Journal of Cancer (Oxford, England : 1990)|May 31, 2023
Minimally important differences for interpreting EORTC QLQ-C30 change scores over time: A synthesis across 21 clinical trials involving nine different cancer typesJammbe Z Musoro, Corneel Coens, Mirjam A G Sprangers, et al.
European Journal of Cancer (Oxford, England : 1990)|November 1, 2025
The use of EORTC QLQ-C30 Summary Score in cancer research and its performance as compared with the EORTC QLQ-C30 Global Health/Quality of Life scale: A systematic review and comparative analysis of effect sizesJosien C C Scheepens, Mogens Groenvold, Johannes M Giesinger, et al.
European Journal of Cancer (Oxford, England : 1990)|May 7, 2026
Prognostic value for overall survival of the EORTC QLQ-C30 Summary Score: An analysis of 5 closed EORTC trialsJosien C C Scheepens, Luigi Lim, Jammbe Z Musoro, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
European Journal of Cancer (Oxford, England : 1990)|October 26, 2018
Interpreting European Organisation for Research and Treatment for Cancer Quality of life Questionnaire core 30 scores as minimally importantly different for patients with malignant melanomaJammbe Z Musoro, Andrew Bottomley, Corneel Coens, et al.
Lung Cancer (Amsterdam, Netherlands)|April 12, 2022
Minimally important differences of EORTC QLQ-C30 scales in patients with lung cancer or malignant pleural mesothelioma - Interpretation guidance derived from two randomized EORTC trialsMichael Koller, Jammbe Z Musoro, Krzysztof Tomaszewski, et al.
JNCI Cancer Spectrum|April 25, 2020
Minimally Important Differences for Interpreting EORTC QLQ-C30 Scores in Patients With Advanced Breast CancerJammbe Z Musoro, Corneel Coens, Frederic Fiteni, et al.
Gynecologic Oncology|September 25, 2020
Minimally important differences for interpreting European Organisation for Research and Treatment of Cancer (EORTC) Quality of life Questionnaire core 30 scores in patients with ovarian cancerJammbe Z Musoro, Corneel Coens, Elfriede Greimel, et al.
Head & Neck|July 7, 2020
Minimally important differences for interpreting European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 scores in patients with head and neck cancerJammbe Z Musoro, Corneel Coens, Susanne Singer, et al.
The Lancet. Oncology|May 4, 2023
Single-arm studies involving patient-reported outcome data in oncology: a literature review on current practiceLimin Liu, Jungyeon Choi, Jammbe Z Musoro, et al.
Neuro-Oncology|February 18, 2021
Establishing anchor-based minimally important differences for the EORTC QLQ-C30 in glioma patientsLinda Dirven, Jammbe Z Musoro, Corneel Coens, et al.
European Journal of Cancer (Oxford, England : 1990)|May 31, 2023
Minimally important differences for interpreting EORTC QLQ-C30 change scores over time: A synthesis across 21 clinical trials involving nine different cancer typesJammbe Z Musoro, Corneel Coens, Mirjam A G Sprangers, et al.
European Journal of Cancer (Oxford, England : 1990)|November 1, 2025
The use of EORTC QLQ-C30 Summary Score in cancer research and its performance as compared with the EORTC QLQ-C30 Global Health/Quality of Life scale: A systematic review and comparative analysis of effect sizesJosien C C Scheepens, Mogens Groenvold, Johannes M Giesinger, et al.
European Journal of Cancer (Oxford, England : 1990)|May 7, 2026
Prognostic value for overall survival of the EORTC QLQ-C30 Summary Score: An analysis of 5 closed EORTC trialsJosien C C Scheepens, Luigi Lim, Jammbe Z Musoro, et al.
Pageof 3